Shavitt RG - Search Results

1

Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.

Costa DLC, Diniz JB, Requena G, Joaquim MA, Pittenger C, Bloch MH, Miguel EC, Shavitt RG. Costa DLC, et al. Among authors: shavitt rg. J Clin Psychiatry. 2017 Jul;78(7):e766-e773. doi: 10.4088/JCP.16m11101. J Clin Psychiatry. 2017. PMID: 28617566 Clinical Trial.

2

The tic-related obsessive-compulsive disorder phenotype and treatment implications.

Miguel EC, do Rosário-Campos MC, Shavitt RG, Hounie AG, Mercadante MT. Miguel EC, et al. Among authors: shavitt rg. Adv Neurol. 2001;85:43-55. Adv Neurol. 2001. PMID: 11530446 Review. No abstract available.

3

Adults with early-onset obsessive-compulsive disorder.

Rosario-Campos MC, Leckman JF, Mercadante MT, Shavitt RG, Prado HS, Sada P, Zamignani D, Miguel EC. Rosario-Campos MC, et al. Among authors: shavitt rg. Am J Psychiatry. 2001 Nov;158(11):1899-903. doi: 10.1176/appi.ajp.158.11.1899. Am J Psychiatry. 2001. PMID: 11691698

4

Impact of age at onset and duration of illness on the expression of comorbidities in obsessive-compulsive disorder.

Diniz JB, Rosario-Campos MC, Shavitt RG, Curi M, Hounie AG, Brotto SA, Miguel EC. Diniz JB, et al. Among authors: shavitt rg. J Clin Psychiatry. 2004 Jan;65(1):22-7. doi: 10.4088/jcp.v65n0104. J Clin Psychiatry. 2004. PMID: 14744164

5

Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder.

Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel EC, Vallada H. Meira-Lima I, et al. Among authors: shavitt rg. Genes Brain Behav. 2004 Apr;3(2):75-9. doi: 10.1046/j.1601-1848.2003.0042.x. Genes Brain Behav. 2004. PMID: 15005715 Free article. Clinical Trial.

6

Clinical features associated to refractory obsessive-compulsive disorder.

Ferrão YA, Shavitt RG, Bedin NR, de Mathis ME, Carlos Lopes A, Fontenelle LF, Torres AR, Miguel EC. Ferrão YA, et al. Among authors: shavitt rg. J Affect Disord. 2006 Aug;94(1-3):199-209. doi: 10.1016/j.jad.2006.04.019. Epub 2006 Jun 9. J Affect Disord. 2006. PMID: 16764938

7

Clinical features associated with treatment response in obsessive-compulsive disorder.

Shavitt RG, Belotto C, Curi M, Hounie AG, Rosário-Campos MC, Diniz JB, Ferrão YA, Pato MT, Miguel EC. Shavitt RG, et al. Compr Psychiatry. 2006 Jul-Aug;47(4):276-81. doi: 10.1016/j.comppsych.2005.09.001. Epub 2006 Apr 19. Compr Psychiatry. 2006. PMID: 16769302

8

Obsessive-compulsive disorder: influence of age at onset on comorbidity patterns.

de Mathis MA, do Rosario MC, Diniz JB, Torres AR, Shavitt RG, Ferrão YA, Fossaluza V, de Bragança Pereira CA, Miguel EC. de Mathis MA, et al. Among authors: shavitt rg. Eur Psychiatry. 2008 Apr;23(3):187-94. doi: 10.1016/j.eurpsy.2008.01.002. Epub 2008 Mar 7. Eur Psychiatry. 2008. PMID: 18329252

9

Sensory phenomena in obsessive-compulsive disorder and tic disorders: a review of the literature.

Prado HS, Rosário MC, Lee J, Hounie AG, Shavitt RG, Miguel EC. Prado HS, et al. Among authors: shavitt rg. CNS Spectr. 2008 May;13(5):425-32. doi: 10.1017/s1092852900016606. CNS Spectr. 2008. PMID: 18496480 Review.

10

Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial.

Diniz JB, Shavitt RG, Pereira CA, Hounie AG, Pimentel I, Koran LM, Dainesi SM, Miguel EC. Diniz JB, et al. Among authors: shavitt rg. J Psychopharmacol. 2010 Mar;24(3):297-307. doi: 10.1177/0269881108099423. Epub 2009 Jan 22. J Psychopharmacol. 2010. PMID: 19164490 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page